Funding, News and Announcements

» Go to news main

Canadian Institutes of Health Research, Joint Programming Initiative on Antimicrobial Resistance

Posted by Jaq-Lin Larder on January 29, 2024 in Research Funding

Antimicrobial resistance (AMR) affects humans, animals and plants without geographic borders or species barriers. Progress on AMR is necessary to achieve the United Nations (UN) Sustainable Development Goals (SDGs).

CIHR is a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), a collaboration between 29 countries that support research in AMR with the goal of achieving long-term reductions in resistance levels and better public health outcomes through national public funding. This call, developed under the ERA-Net JPIAMR-ACTION, is the 17th JPIAMR transnational call for research projects.

The objectives of this funding opportunity are to:

  • Design novel or improved interventions to prevent, mitigate, and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
  • Improve and/or compare and/or evaluate strategies, technologies, treatments, methods, protocols, or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

The application process for this funding opportunity is comprised of two steps:

  1. Pre-proposal to JPIAMR
  2. Full Proposal to JPIAMR and Abbreviated Application to CIHR (invitations for the Full Proposal are expected to be sent by May 30, 2024).

Full details about this call and the application process can be found here.


Deadlines for Pre-Proposal

Internal: February 29, 2024. Contact email is ird@dal.ca

Funder: March 14, 2024. Contact email is support-soutien@cihr-irsc.gc.ca